TScan Therapeutics, Inc. (TCRX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$1.1
Day's range
$1.25

Tscan Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
LYNX1 CAPITAL MANAGEMENT LP 08/13/2026 8.02 M $7.86 M   0.00% 6.17%
BVF INC/IL 08/14/2026 5.56 M $5.45 M   0.00% 4.28%
BAKER BROS. ADVISORS LP 08/14/2026 2.78 M $2.73 M   0.00% 2.14%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 2.16 M $2.12 M   0.21% 1.66%
TWO SIGMA INVESTMENTS, LP 08/14/2026 1.95 M $1.91 M   61.26% 1.50%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 1.33 M $1.30 M   -2.78% 1.02%
ACADIAN ASSET MANAGEMENT LLC 08/13/2026 1.31 M $1.28 M   546.50% 1.00%
DEER MANAGEMENT CO. LLC 08/14/2026 1.25 M $1.22 M   0.00% 0.96%
MILLENNIUM MANAGEMENT LLC 08/14/2026 1.16 M $1.14 M   -20.32% 0.90%
JACOBS LEVY EQUITY MANAGEMENT, INC 08/14/2026 1.05 M $1.03 M   29.87% 0.81%
CITADEL ADVISORS LLC 09/02/2026 1.01 M $989.03 K   216.92% 0.78%
BLACKROCK, INC. 08/07/2026 994.65 K $974.86 K   -45.97% 0.77%
BOOTHBAY FUND MANAGEMENT, LLC 08/14/2026 772.24 K $756.87 K   100.00% 0.59%
MARSHALL WACE, LLP 08/13/2026 687.36 K $673.62 K   189.60% 0.53%
DC FUNDS, LP 08/14/2026 630.00 K $617.46 K   0.00% 0.48%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 584.81 K $573.40 K   -5.21% 0.45%
D. E. SHAW & CO., INC. 08/14/2026 548.40 K $537.49 K   71.60% 0.42%
GSA CAPITAL PARTNERS LLP 08/06/2026 548.09 K $537.00 K   44.63% 0.42%
KALEHUA CAPITAL MANAGEMENT LLC 08/19/2026 454.88 K $445.82 K   100.00% 0.35%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 363.95 K $356.68 K   19.03% 0.28%
JANE STREET GROUP, LLC 08/14/2026 241.49 K $236.69 K   67.21% 0.19%
VERDAD ADVISERS, LP 08/14/2026 232.76 K $228.13 K   73.70% 0.18%
STATE STREET CORP 08/07/2026 207.31 K $203.19 K   0.00% 0.16%
MIZUHO SECURITIES USA LLC 07/28/2026 205.60 K $201.51 K   100.00% 0.16%
MORGAN STANLEY 08/13/2026 197.89 K $193.95 K   13.96% 0.15%
HRT FINANCIAL LP 08/14/2026 164.60 K $161.00 K   100.00% 0.13%
XTX TOPCO LTD 08/14/2026 149.47 K $146.49 K   146.16% 0.12%
BROWN BROTHERS HARRIMAN & CO 08/12/2026 143.05 K $140.20 K   0.00% 0.11%
NORTHERN TRUST CORP 08/13/2026 138.78 K $136.02 K   42.41% 0.11%
LETKO, BROSSEAU & ASSOCIATES INC 08/13/2026 95.88 K $93.97 K   0.00% 0.07%
NEWEDGE WEALTH, LLC 08/10/2026 91.46 K $89.64 K   0.00% 0.07%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 08/14/2026 76.90 K $75.37 K   -31.28% 0.06%
GOLDMAN SACHS GROUP INC 08/14/2026 70.51 K $69.11 K   89.21% 0.05%
AMERIPRISE FINANCIAL INC 08/14/2026 69.49 K $68.10 K   32.02% 0.05%
UBS GROUP AG 08/13/2026 68.87 K $67.50 K   112.02% 0.05%
STIFEL FINANCIAL CORP 08/12/2026 68.20 K $66.84 K   -1.73% 0.05%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 65.34 K $64.03 K   0.00% 0.05%
KESTRA ADVISORY SERVICES, LLC 07/28/2026 62.53 K $61.28 K   0.00% 0.05%
BANK OF AMERICA CORP /DE/ 08/14/2026 49.10 K $48.12 K   -14.65% 0.04%
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO 08/17/2026 36.60 K $35.87 K   32.13% 0.03%
DC INVESTMENTS MANAGEMENT, LLC 08/14/2026 35.56 K $34.86 K   100.00% 0.03%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 08/12/2026 25.86 K $25.35 K   100.00% 0.02%
HSBC HOLDINGS PLC 08/14/2026 24.57 K $23.84 K   0.00% 0.02%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 23.62 K $23.15 K   -84.98% 0.02%
BARCLAYS PLC 08/14/2026 19.17 K $18.79 K   12.24% 0.01%
R SQUARED LTD 08/05/2026 18.36 K $18.00 K   100.00% 0.01%
VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC 08/11/2026 17.96 K $17.60 K   -15.92% 0.01%
JPMORGAN CHASE & CO 08/12/2026 16.46 K $16.09 K   0.13% 0.01%
VANGUARD GLOBAL ADVISERS, LLC 08/13/2026 15.71 K $15.39 K   0.00% 0.01%
ADVISOR GROUP HOLDINGS, INC. 08/14/2026 12.25 K $12.00 K   25.51% 0.01%

Tscan Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 76 institutional investors and hedge funds held shares of Tscan Therapeutics Inc. The most heavily invested institutionals were:

Lynx1 Capital Management LP: 8.02 M

BVF INC/IL: 5.56 M

BAKER BROS. ADVISORS LP: 2.78 M

VANGUARD CAPITAL MANAGEMENT LLC: 2.16 M

TWO SIGMA INVESTMENTS, LP: 1.95 M

RENAISSANCE TECHNOLOGIES LLC: 1.33 M

27.58% of Tscan Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 44.72 M shares in the last 24 months. This purchase volume represents approximately $55.45 M in transactions.